Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Commentary
Editorial
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medical Innovator
Mini-Review
Original Article
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Commentary
Editorial
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medical Innovator
Mini-Review
Original Article
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Commentary
Editorial
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medical Innovator
Mini-Review
Original Article
Review Article
Short Communication
View/Download PDF

Translate this page into:

Review Article
2023
:18;
28
doi:
10.25259/GJMPBU_31_2023

The Emerging Role of Vitamin D in Neurological Health and Disease

Department of Biochemistry, Combined Military Hospital Lahore Medical College and Institute of Dentistry (National University of Medical Sciences), Lahore, Pakistan.

*Corresponding author: Syed Imran Ali Shah, Department of Biochemistry, Combined Military Hospital Lahore Medical College and Institute of Dentistry (National University of Medical Sciences), Lahore, Pakistan. s.shah10@alumni.imperial.ac.uk

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Noor A, Shah SIA. The Emerging Role of Vitamin D in Neurological Health and Disease. Glob J Med Pharm Biomed Update 2023;18:28.

Abstract

Vitamin D has come up as a pluripotent biochemical modulator of several systemic functions including its well-established musculoskeletal effects functioning as well as other key roles in nervous, cardiac, immune, vascular, and endocrinological systems. It undergoes metabolic activation in the skin, liver, and kidneys to exert its systemic actions primarily through Vitamin D receptor-mediated gene expression. In recent times, the involvement of Vitamin D has been documented in the regulation of neurotrophins, neural differentiation, and maturation, and the synthesis of neuromodulators including acetylcholine, dopamine, and gamma-aminobutyric acid. Clinical studies have also highlighted the involvement of Vitamin D in neurological disorders, thereby underscoring its potential in the clinical management of such disorders. Further, research is required to determine the multipronged roles of Vitamin D and its molecular pathways in neurophysiology for the potential prevention and treatment of neurological dysfunction.

Keywords

Cholecalciferol
Vitamin D
Nervous system
Neurological health
Neurological disease

INTRODUCTION

A lipid-soluble vitamin, Vitamin D (calciferol), belongs to the family of steroidal agents and is present in two different forms in plants and animals, namely, ergocalciferol (D2) and cholecalciferol (D3), respectively [Figure 1]. It acts as a hormone and affects different body organs with major actions on bones, intestines, and kidneys for the regulation of mineral homeostasis, specifically phosphorus, and calcium.[1] Calciferol is involved in numerous physiological functions and alterations in its concentrations and signaling pathways are associated with various pathological conditions.[2]

Biochemical features of Vitamin D.
Figure 1:
Biochemical features of Vitamin D.

Increasing evidence from recent research studies has pointed out the complex and crucial role of Vitamin D in the development and functioning of the nervous system including the brain, spinal cord, and related structures through modulation of many important processes including cellular proliferation, differentiation, immunoregulation, and neuroprotection.[3] The current review recaps the salient features of Vitamin D and revisits the evidence accrued thus far on its neurological functions and related clinical disorders [Table 1] An extensive literature exploration was carried out on this topic using databases, including Google Scholar, PubMed, Scopus, and Web of Science.

Table 1: Vitamin D in neurophysiology, neuropathology, and neurocognitive disorders.
Physiological mechanism Pathological outcome in Vitamin D deficiency Associated clinical disease
Neuroprotective function, regulation of gene expression, thrombolytic property, vasodilation, and antioxidant action Neurodisruption, vasoconstriction, and disintegration of blood-brain barrier Cerebrovascular accidents (Stroke)
Clearance of amyloid plaque Accumulation of amyloid plaque Alzheimer’s disease
Neuroprotection, anti-inflammatory effects, and anti-oxidant response Neuroinflammation, memory loss, and disorientation Cognitive dysfunction
Restoration of dopamine levels Defective neurotransmission Parkinson’s disease
Immunomodulation, modulation of interleukins and lymphocytes, and calcium homeostasis Immune dysregulation and calcium imbalance Multiple sclerosis
Neurotrophic support and antioxidant activity Oxidative damage Amyotrophic lateral sclerosis

VITAMIN D BIOCHEMISTRY

Dietary sources and metabolic activation

Naturally, Vitamin D is processed in the epidermis of the skin through the conversion of 7-dehydrocholesterol provided by the diet or produced endogenously in the presence of sunlight.

The dietary sources of Vitamin D include the yolk of eggs, different varieties of fish, margarine, fish oil, as well as Vitamin D-boosted products[2] [Figure 1]. The diet-obtained or cutaneous form of Vitamin D is inactive and requires two steps of hydroxylation. The steps primarily take place in the liver with the help of 25-hydroxylase, and in other organs including the prostate glands, kidneys, brain, placenta, and the immune system in the presence of 1-α-hydroxylase, forming active form of Vitamin D or 1,25-dihydroxycholecalciferol, also called calcitriol[2,4] [Figure 2]. In the serum, Vitamin D is predominantly present in the single hydroxylated form of 25-hydroxycholecalciferol. This form has less affinity for Vitamin D receptor (VDR) than the active 1,25-dihydroxycholecalciferol.[5] This hormone-like vitamin is associated with systemic disorders such as heart diseases, vascular problems, malignant tumors, brain hemorrhages, and diabetes mellitus to name a few. Vitamin D deficiency has also been associated with the impairment of cognition and dementia as well as psychiatric conditions such as psychosis and autism in addition to its well-established skeletal abnormalities including rickets and osteomalacia.[6] Hypervitaminosis D is not common but may cause severe health issues like hypercalcemia. The toxicity of Vitamin D occurs as a result of excessive ingestion of foods rich in Vitamin D or overdose with Vitamin D containing drugs either when administered repetitively or taken in a large dose.[7] The sign and symptoms resulting from Vitamin D toxicity are varied and typically include anxiety, confusion, gastric disturbances, cardiac impairment, and kidney dysfunction.[8]

Structure of Vitamin D and its active metabolite.
Figure 2:
Structure of Vitamin D and its active metabolite.

Receptor mechanism

The active form of Vitamin D exerts its function through genomic and non-genomic actions. In genomic actions, intracellular VDR that belongs to the nuclear receptors group is activated by Vitamin D to affect the target cell. VDR acts as a transcriptional factor and changes the expression of genes linked with different metabolic pathways. VDR has been found in almost all types of cells, which may elaborate its many functions in different tissues[9] [Figure 1]. 1,25-dihydroxycholecalciferol may act through another type of receptor present in the plasma membrane as membrane-associated rapid response steroid-binding (MARRS) receptors. These MARRS receptors help the hormonal form of Vitamin D in the regulation of calcium concentration in the cytosol.[2]

EFFECTS OF VITAMIN D ON NEUROLOGICAL HEALTH

Vitamin D is a neuroactive steroid that regulates various neurological functions in the body. Cholecalciferol and its metabolites are penetrable through the blood–brain barrier and can be metabolized locally due to the presence of VDR and enzyme CYP27B1 for the formation and CYP24A1 for the degradation of Vitamin D and its metabolites in neural cells.[10-12]

Location of receptors

The receptors for Vitamin D, VDR, are present almost in every tissue of the human body and their distribution is similar to that seen in rats and hamsters.[3] These receptors are located in different parts of the brain and spinal cord including the hippocampus, hypothalamus, thalamus, ventricles, cortex, cerebellum, and substantia nigra. The localization of VDR in various brain areas has helped in the identification of specific roles of Vitamin D in various neurological functions.[13]

Neurological development

Vitamin D imparts great benefits to neurological development and growth.[14] In the human brain, production of the active form of Vitamin D occurs in the neonatal and adult brains due to the presence of the gene CYP27B1, which is responsible for the synthesis of the enzyme that converts the inactive form to the active form.[15,16]

Vitamin D has been reported to affect the elementary processes in fetal brain development, involving changes in synapses and the support of the cytoskeleton.[17] In addition, new mechanisms have revealed how Vitamin D earmarks gene expression and alteration of Vitamin D signaling could affect critical events such as the elongation of exons, neurotransmitter synthesis, and production of neurotrophin in the development and functioning of the brain[16] [Figure 3].

Vitamin D-mediated mechanisms implicated in the maintenance of neurological health.
Figure 3:
Vitamin D-mediated mechanisms implicated in the maintenance of neurological health.

Calciferol contributes to the development of dopaminergic neurons. At first, VDR was found in the substantia nigra[18,19] During the development phase, Vitamin D deficiency has been shown to decrease certain factors that are mandatory for the growth of neurons involved in dopamine synthesis, change the turnover of dopamine, and interfere with the formation of substantia nigra.[20-22] These abnormalities due to maternal deficiency of Vitamin D can be avoided with cautious supplementation of Vitamin D during pregnancy under medical advice.[23] Vitamin D is postulated to interact with nervous tissue extracellular matrix aggregates and perineuronal nets to regulate brain plasticity and Vitamin D deficiency-induced dysregulation of these interactions may manifest as neurologic deficits which can have implications in neuropsychiatric disorders.[24,25] Vitamin D supplementation in age-related cognitive decline in rats has been shown to modulate synaptic plasticity and improve cognitive function.[26]

Actions on the central nervous system (CNS)

Vitamin D promotes genomic expression in the brain through the linkage of the VDR/retinoic acid receptor complex with the Vitamin D-responsive elements in the CNS.[27] It influences the release of neurotransmitters in CNS and affects multiple neuronal functions including differentiation of cells, neurotrophin expression, movement of calcium ions, reduction in oxidative stress and inflammation, and normal physiology of neurons through the manipulation of genetic expression[14] [Figure 3].

Actions on the peripheral nervous system (PNS)

The PNS connects the CNS with the peripheral organs. Cells of PNS are involved more in nerve regeneration than CNS.[28] Both VDR and 1-α-hydroxylase enzymes are present in the Schwan cells and peripheral glial cells that affect the excitatory conduction velocity of motor neurons, modulate the production of growth factors, and provide aid in injury and restoration of nerve.[29]

Actions on the autonomic nervous system (ANS)

The sympathetic and parasympathetic systems constituting the ANS are considered a fundamental component of the peripheral efferent nervous system, which modulates the functions of visceral organs, endocrine glands, and the smooth muscle of blood vessels.[30] This system innervates nearly all organs of the body.[31-33] Vitamin D contributes to the stability of the autonomic system and potentially behaves as the chief neuroactive substance. It affects the autonomic activities of the brain, heart, and digestive system by acting as an antioxidant and releasing serotonin.[34,35]

Cognitive physiology and psychology

VDRs in the different neuronal cells are responsible for cognitive function and demonstrating these roles through mechanisms such as neuroprotective induction, oxidative stress modification, inflammatory suppression, and calcium balance[36] [Figure 3]. In elderly patients, there is an association between cholecalciferol and white matter disease of the brain.[37] A positive correlation has been reported between Vitamin D levels and the concentration of neurotrophic growth factor, neurogelin-1 (NRG1) has been shown along with an association between the concentration of NRG1 and symptoms of schizophrenia. While a direct link between Vitamin D concentrations and schizophrenia symptoms was not observed, there is a possibility that the relationship may be mediated through NRG1.[38]

ALTERED VITAMIN D STATUS AND NEUROLOGICAL DYSFUNCTION

Cerebrovascular accidents (CVA)

CVAs are the major reason for significant long-term disability worldwide and are an immense source of the global disease burden. Low Vitamin D levels are linked to a heightened risk of vascular diseases including CVA. Deficits of Vitamin D have been shown to be one of the factors responsible for endothelial dysfunction.[39] Vitamin D deficiency has been suggested as an independent risk factor for the occurrence of acute ischemic stroke.[40] The exact mechanism of altered levels of Vitamin D leading to stroke has not been elucidated yet. The neuroprotective action of Vitamin D takes effect by its regulation of the gene expression of insulin-like growth factor that has anti-thrombolytic properties and helps in dendritic and axonal degeneration. 1,25-dihydroxycholecalciferol helps in vasodilation and activation of nitric oxide synthase, thereby facilitating the reduction of blood pressure directly and indirectly by inhibiting the renin-angiotensin system that is a potent vasoconstrictor.[41] Low levels of Vitamin D are linked to vascular stiffness and reduction in the diameter of blood vessels which may lead to their occlusion.[42] Research on rat models has revealed its function as an antioxidant that helps in the prevention of the destruction of blood–brain barrier integrity after stroke.[43]

Alzheimer’s disease

Alzheimer’s disease is the most common cause of dementia, characterized by memory loss and deteriorating cognition. Pathologically, extracellular amyloid-beta (Aβ) plaques and intracellular neurofibrillary tangles primarily describe Alzheimer’s disease.[44] In the processing pathway of Aβ in neuronal cultures, cholecalciferol modulates gene expression and helps in the clearance of amyloid plaque. Hence, Vitamin D deficiency may result in Alzheimer’s pathology through disturbed gene expression.[45] Supplementation with Vitamin D has been shown to improve the brain’s memory function through a potential reversal of amyloidopathy.[46]

Cognitive dysfunction

Vitamin D deficiency is associated with different cognitive dysfunctions including schizophrenia, sadness, and loss of attention.[24] A number of observational studies have reported the association between a decline in cognitive function and a decreased level of Vitamin D in serum.[47,48] The exact mechanisms of Vitamin D-related cognitive decline are not known, though the neuroprotective properties, anti-inflammatory actions, and antioxidant effects of Vitamin D may possibly serve its potential as a modifiable risk factor for cognitive disease.[36]

Parkinson’s disease

Parkinson’s disease is a neurodegenerative disorder characterized by the loss of neurons of the substantia nigra that produces dopamine. The degeneration of dopaminergic pathways induces motor and non-motor dysfunction in the body. Multiple studies have shown the relationship between decreased serum Vitamin D levels and an increased risk of Parkinson’s disease.[49,50] VDR and 1-α-hydroxylase are present in substantia nigra. The neuroprotective action of Vitamin D helps maintain dopamine levels by upregulating the nerve growth factor.[51,52]

Multiple sclerosis and amyotrophic lateral sclerosis

A neurological autoimmune disorder, multiple sclerosis affects the brain and spinal cord through the demyelination of nerve fibers.[53,54] Scientific studies have suggested that hypovitaminosis D contributes as a negative element in the development of multiple sclerosis. The exact pathophysiology of this is not known yet, but Vitamin D’s role as a neuroimmunomodulator and its actions on interleukins and lymphocytes may be involved.[55,56] Vitamin D and aerobic training have recently been shown to positively modulate neurotrophic and inflammatory profiles in female patients with multiple sclerosis.[57] Amyotrophic lateral sclerosis is a neurological illness characterized by the deterioration of motor neurons. The disruption of the neuroprotective effects of Vitamin D through the reduction of oxidative stress is thought to play a role in the pathogenesis of amyotrophic lateral sclerosis.[58]

CONCLUSION

Vitamin D has been highlighted as a crucial micronutrient in neural development, growth, and maturation. Recent work has also pointed out the link between Vitamin D and diseases that cause neurocognitive dysfunction such as Parkinson’s and Alzheimer’s. However, most of the work has been limited by a lack of resources, inadequate study designs, inappropriate statistical analyses, and insufficient scientific documentation. It is imperative to undertake properly designed laboratory studies exploring the biochemical signaling pathways of Vitamin D to potentially determine the preventive and therapeutic molecular targets of neurologic pathologies. Vitamin D may then be incorporated as a synergistic agent in the treatment regimens of implicated neurological deficits based on evidence gathered from future interventional studies and randomized control trials.

Declaration of patient consent

Patient’s consent not required as there are no patients in this study.

Conflicts of interest

There are no conflicts of interest

Use of artificial intelligence (AI)-assisted technology for manuscript preparation

The authors confirm that there was no use of Artificial Intelligence (AI)-Assisted Technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship

Nil.

References

  1. , , . Immunomodulatory Role of Vitamin D: Clinical Implications in Infections and Autoimmune Disorders. Gomal J Med Sci. 2020;18:132-8.
    [CrossRef] [Google Scholar]
  2. , , , . Vitamin D and the Nervous System. Neurol Res. 2019;41:827-35.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , , . Review: The Role of Vitamin D in Nervous System Health and Disease. Neuropathol Appl Neurobiol. 2013;39:458-84.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , . Molecular Mechanisms of Vitamin D-Mediated Immunomodulation. Galen Med J. 2021;10:e2097.
    [CrossRef] [PubMed] [Google Scholar]
  5. . Effects of Vitamin D in the Nervous System: Special Focus on Interaction with Steroid Hormone Signalling and a Possible Role in the Treatment of Brain Cancer. J Neuroendocrinol. 2020;32:e12799.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , , . The Role of Vitamin D in Brain Health: A Mini Literature Review. Cureus. 2018;10:e2960.
    [CrossRef] [Google Scholar]
  7. , , , , . Vitamin D Toxicity-A Clinical Perspective. Front Endocrinol (Lausanne). 2018;9:550.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , . Vitamin D: Not Just the Bone. Evidence for Beneficial Pleiotropic Extraskeletal Effects. Eat Weight Disord. 2016;22:27-41.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , . Vitamin D: Classic and Novel Actions. Ann Nutr Metab. 2018;72:87-95.
    [CrossRef] [PubMed] [Google Scholar]
  10. . Vitamin D and brain health: The Need for Vitamin D Supplementation and Sensible Sun Exposure. J Intern Med. 2015;277:90-3.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , . Developmental Vitamin D Deficiency and Autism: Putative Pathogenic Mechanisms. J Steroid Biochem Mol Biol. 2018;175:108-18.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , , , , , et al. The Influence of Vitamin D on Neurodegeneration and Neurological Disorders: A Rationale for Its Physio-Pathological Actions. Curr Pharm Des. 2020;26:2475-91.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , . Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact. Int J Mol Sci. 2018;19:2245.
    [CrossRef] [PubMed] [Google Scholar]
  14. , . Vitamin D and the Central Nervous System: Causative and Preventative Mechanisms in Brain Disorders. Nutrients. 2022;14:4353.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , , , et al. Extrarenal Expression of 25-Hydroxyvitamin d(3)-1 Alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86:888-94.
    [CrossRef] [PubMed] [Google Scholar]
  16. . Vitamin D: Brain and Behavior. JBMR Plus. 2021;5:e10419.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , , , et al. Non-Skeletal Activities of Vitamin D: From Physiology to Brain Pathology. Medicina (Kaunas). 2019;55:341.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , , . Distribution of the Vitamin D Receptor and 1α-Hydroxylase in Human Brain. J Chem Neuroanat. 2005;29:21-30.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , , , , . The Vitamin D Receptor in Dopamine Neurons; Its Presence in Human Substantia Nigra and Its Ontogenesis in Rat Midbrain. Neuroscience. 2013;236:77-87.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , , . Maternal Vitamin D Deficiency Alters the Expression of Genes Involved in Dopamine Specification in the Developing rat Mesencephalon. Neurosci Lett. 2010;486:220-3.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , , , , . Developmental Vitamin D Deficiency Alters Dopamine Turnover in Neonatal Rat Forebrain. Neurosci Lett. 2009;461:155-8.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , , , , , et al. Developmental Vitamin D (DVD) Deficiency Reduces Nurr1 and TH Expression in Post-Mitotic Dopamine Neurons in Rat Mesencephalon. Mol Neurobiol. 2018;55:2443-53.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , , . Maternal Vitamin D Prevents Abnormal Dopaminergic Development and Function in a Mouse Model of Prenatal Immune Activation. Sci Rep. 2018;8:9741.
    [CrossRef] [PubMed] [Google Scholar]
  24. , . Vitamin D in Synaptic Plasticity, Cognitive Function, and Neuropsychiatric Illness. Trends Neurosci. 2019;42:293-306.
    [CrossRef] [PubMed] [Google Scholar]
  25. , , , , , , et al. Vitamins D and B12, Altered Synaptic Plasticity and Extracellular Matrix In: LeBlanc JG. editor. B-Complex Vitamins. Rijeka: IntechOpen; .
    [Google Scholar]
  26. , , , , , , et al. Co-Treatment of Vitamin D Supplementation with Enriched Environment Improves Synaptic Plasticity and Spatial Learning and Memory in Aged Rats. Psychopharmacology. 2021;238:2297-312.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , . Vitamin D and the Brain: Genomic and Non-genomic Actions. Mol Cell Endocrinol. 2017;453:131-43.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , , . Neuron-fibrous Scaffold Interfaces in the Peripheral Nervous System: A Perspective on the Structural Requirements. Neural Regen Res. 2022;17:1893-7.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , , , . Low Vitamin D is Associated with Diabetes Peripheral Neuropathy in Older but not in Young and Middle-aged Patients. Diabetes Metab Res Rev. 2019;35:e3162.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , . Overview of the Anatomy, Physiology, and Pharmacology of the Autonomic Nervous System. Compr Physiol. 2016;37:125.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , , , , , et al. Effects of Vitamin D Deficiency on the Function of the Cardiac Autonomic Nervous System in Rats. Cardiovasc Ther. 2022;2022:4366948.
    [CrossRef] [PubMed] [Google Scholar]
  32. , , , , , , et al. Mechanisms Underpinning Sympathetic Nervous Activity and Its Modulation Using Transcutaneous Vagus Nerve Stimulation. Exp Physiol. 2018;103:326-31.
    [CrossRef] [PubMed] [Google Scholar]
  33. . Basics of Autonomic Nervous System Function. Handb Clin Neurol. 2019;160:407-18.
    [CrossRef] [PubMed] [Google Scholar]
  34. . Is Vitamin D Deficiency Implicated in Autonomic Dysfunction? J Pediatr Neurosci. 2017;12:119-23.
    [CrossRef] [PubMed] [Google Scholar]
  35. , . Vitamin D Hormone Regulates Serotonin Synthesis. Part 1: Relevance for Autism. FASEB J. 2014;28:2398-413.
    [CrossRef] [PubMed] [Google Scholar]
  36. , . Role of Vitamin D in Cognitive Dysfunction: New Molecular Concepts and Discrepancies between Animal and Human Findings. Nutrients. 2021;13:3672.
    [CrossRef] [PubMed] [Google Scholar]
  37. , , , , , , et al. Association of White Matter Hyperintensities with Low Serum 25-Hydroxyvitamin D Levels. AJNR Am J Neuroradiol. 2014;35:1145-9.
    [CrossRef] [PubMed] [Google Scholar]
  38. , , , , , . Vitamin D and Neurotrophin Levels and Their Impact on the Symptoms of Schizophrenia. Neuropsychobiology. 2019;79:179-85.
    [CrossRef] [PubMed] [Google Scholar]
  39. , , , , , , et al. Vitamin D Deficiency is Associated with Acute Ischemic Stroke, C-reactive Protein, and Short-term Outcome. Metab Brain Dis. 2017;32:493-502.
    [CrossRef] [PubMed] [Google Scholar]
  40. , , , , . 25-Hydroxyvitamin D Levels and the Risk of Stroke: A Prospective Study and Meta-analysis. Stroke. 2012;43:1470-7.
    [CrossRef] [PubMed] [Google Scholar]
  41. , , . Vitamin D and Stroke: Effects on Incidence, Severity, and Outcome and the Potential Benefits of Supplementation. Front Neurol. 2020;11:384.
    [CrossRef] [PubMed] [Google Scholar]
  42. , . Low Vitamin D Levels are Associated with the Development of Deep Venous Thromboembolic Events in Patients with Ischemic Stroke. Clin Appl Thromb Hemost. 2018;24(9_suppl):69s-75.
    [CrossRef] [PubMed] [Google Scholar]
  43. , , , , , . Vitamin D Prevents Hypoxia/Reoxygenation-Induced Blood-brain Barrier Disruption via Vitamin D Receptor-Mediated NF-kB Signaling Pathways. PLoS One. 2015;10:e0122821.
    [CrossRef] [PubMed] [Google Scholar]
  44. , , , , , . Astrocyte Biomarkers in Alzheimer's Disease. Trends Mol Med. 2019;25:77-95.
    [CrossRef] [PubMed] [Google Scholar]
  45. , , , , , , et al. The Role of Vitamin D as a Biomarker in Alzheimer's Disease. Brain Sci. 2021;11:334.
    [CrossRef] [PubMed] [Google Scholar]
  46. , , , , . The Role of Vitamin D in Alzheimer's Disease: A Transcriptional Regulator of Amyloidopathy and Gliopathy. Biomedicines. 2022;10:1824.
    [CrossRef] [PubMed] [Google Scholar]
  47. , , , , , . The Association between Serum Vitamin D Level and Cognitive Function in Older Adults: Cooper Center Longitudinal Study. Prev Med. 2018;113:57-61.
    [CrossRef] [PubMed] [Google Scholar]
  48. , , , , , , et al. Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. JAMA Neurol. 2015;72:1295-303.
    [CrossRef] [PubMed] [Google Scholar]
  49. , , , , , . Association between Serum Vitamin D Levels and Parkinson's Disease: A Systematic Review and Meta-analysis. Front Neurol. 2018;9:909.
    [CrossRef] [PubMed] [Google Scholar]
  50. . Extra-Skeletal Effects of Vitamin D. Front Hormone Res. 2018;50:72-88.
    [CrossRef] [PubMed] [Google Scholar]
  51. , . A Review of the Relationship between Vitamin D and Parkinson Disease Symptoms. Front Neurol. 2020;11:454.
    [CrossRef] [PubMed] [Google Scholar]
  52. , , , , , , et al. The Influence of Vitamin D on Neurodegeneration and Neurological Disorders: A Rationale for its Physio-Pathological Actions. Curr Pharm Des. 2020;26:1-16.
    [CrossRef] [PubMed] [Google Scholar]
  53. , . Vitamin D in Multiple Sclerosis-Lessons from Animal Studies. Front Neurol. 2021;12:757795.
    [CrossRef] [PubMed] [Google Scholar]
  54. , , . Vitamin D and Multiple Sclerosis: A Comprehensive Review. Neurol Ther. 2018;7:59-85.
    [CrossRef] [PubMed] [Google Scholar]
  55. , , , . A Brief Review of the Effects of Vitamin D on Multiple Sclerosis. Front Immunol. 2020;11:781.
    [CrossRef] [PubMed] [Google Scholar]
  56. , , . Immunomodulatory Effects of Vitamin D in Multiple Sclerosis. Brain. 2009;132:1146-60.
    [CrossRef] [PubMed] [Google Scholar]
  57. , , . Home-Based Aerobic Training and Vitamin D Improve Neurotrophins and Inflammatory Biomarkers in MS Patients. Mult Scler Relat Disord. 2022;60:103693.
    [CrossRef] [PubMed] [Google Scholar]
  58. , , , , . Amyotrophic Lateral Sclerosis: A Diet Review. Foods. 2021;10:3128.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections